Welcome to LookChem.com Sign In|Join Free

CAS

  • or

85502-87-0

Post Buying Request

85502-87-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

85502-87-0 Usage

Description

(2E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one is an organic compound characterized by its molecular formula C16H13ClO2. It is a ketone with a chlorophenyl group and a methoxyphenyl group attached to a prop-2-en-1-one chain. (2E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one exhibits diverse biological activities and has potential applications in the pharmaceutical and agrochemical industries. However, it is important to handle it with caution due to its potential toxic or irritant effects. Further research is necessary to fully understand its potential uses and risks.

Uses

Used in Pharmaceutical Industry:
(2E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one is used as a pharmaceutical intermediate for the development of drugs with diverse biological activities. Its unique structure allows for the creation of new compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, (2E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one is used as a precursor for the synthesis of agrochemicals with potential pesticidal or herbicidal properties. Its chemical structure can be modified to create new compounds with improved efficacy and selectivity in controlling pests and weeds.

Check Digit Verification of cas no

The CAS Registry Mumber 85502-87-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,5,0 and 2 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 85502-87:
(7*8)+(6*5)+(5*5)+(4*0)+(3*2)+(2*8)+(1*7)=140
140 % 10 = 0
So 85502-87-0 is a valid CAS Registry Number.

85502-87-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Propen-1-one, 1-(4-chlorophenyl)-3-(4-methoxyphenyl)-, (2E)-

1.2 Other means of identification

Product number -
Other names 1-(4-CHLOROPHENYL)-3-(4-METHOXYPHENYL)PROP-2-EN-1-ONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:85502-87-0 SDS

85502-87-0Relevant articles and documents

Synthesis, characterization, crystal structure, TGA and blue fluorescence of 6-(4-chlorophenyl)-4-(4-methoxyphenyl)-2-methoxynicotinonitrile

Suwunwong, Thitipone,Chantrapromma, Suchada,Fun, Hoong-Kun

, p. 538 - 543 (2013)

6-(4-Chlorophenyl)-4-(4-methoxyphenyl)-2-methoxynicotinonitrile (1) was synthesized by cyclization reaction of a chalcone derivative and malononitrile and characterized by FT-IR, UV-Vis, 1H NMR and single crystal X-ray diffraction. The crystal

From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity

Abdel-Halim, Mohammad,Sigler, Sara,Racheed, Nora A. S.,Hefnawy, Amr,Fathalla, Reem K.,Hammam, Mennatallah A.,Maher, Ahmed,Maxuitenko, Yulia,Keeton, Adam B.,Hartmann, Rolf W.,Engel, Matthias,Piazza, Gary A.,Abadi, Ashraf H.

supporting information, p. 4462 - 4477 (2021/05/04)

A ligand-based approach involving systematic modifications of a trisubstituted pyrazoline scaffold derived from the COX2 inhibitor, celecoxib, was used to develop novel PDE5 inhibitors. Novel pyrazolines were identified with potent PDE5 inhibitory activit

Novel potent and selective DPP-4 inhibitors: Design, synthesis and molecular docking study of dihydropyrimidine phthalimide hybrids

Mourad, Ahmed A. E.,Khodir, Ahmed E.,Saber, Sameh,Mourad, Mai A. E.

, p. 1 - 24 (2021/02/26)

Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors have emerged as antihyperglycemic agents that improve glycemic control in type 2 diabetic patients, either as monotherapy or in combination with other antidiabetic drugs. Methods: A novel series of dihydropyrimidine phthalimide hybrids was synthesized and evaluated for their in vitro and in vivo DPP-4 inhibition activity and selectivity using alogliptin as reference. Oral glucose tolerance test was assessed in type 2 diabetic rats after chronic treatment with the synthesized hybrids ± metformin. Cytotoxicity and antioxidant assays were performed. Additionally, molecular docking study with DPP-4 and structure activity relationship of the novel hybrids were also studied. Results: Among the synthesized hybrids, 10g, 10i, 10e, 10d and 10b had stronger in vitro DPP-4 inhibitory activity than alogliptin. Moreover, an in vivo DPP-4 inhibition assay revealed that 10g and 10i have the strongest and the most extended blood DPP-4 inhibitory activity compared to alogliptin. In type 2 diabetic rats, hybrids 10g, 10i and 10e exhibited better glycemic control than alogliptin, an effect that further supported by metformin combination. Finally, 10j, 10e, 10h and 10d had the highest radical scavenging activity in DPPH assay. Conclusions: Hybrids 10g, 10i and 10e are potent DPP-4 inhibitors which may be beneficial for T2DM treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 85502-87-0